Peptides & GLP-1's

Weight Loss Near Me has partnered with EllieMD  a telehealth platform that provides personalized, prescription-based programs designed to support weight management, metabolic health, and longevity. Getting started is simple. You’ll begin by completing a secure online medical intake form that provides the provider with details about your health history, medications, and goals. Once submitted, a state-licensed MD or DO will review your intake and determine the most appropriate treatment plan for you. Depending on your state, your consultation may occur via secure messaging or a video visit. After approval, your customized medication is prescribed and shipped directly from a licensed 503A compounding pharmacy to your doorstep. You’ll then gain access to ongoing provider messaging, community support, and educational resources designed to help you succeed.

Weight loss varies by individual. Some patients begin noticing changes within the first few weeks, while others may take a month or more. Staying consistent and following the provider’s dosing plan is key. A safe and steady rate of loss is typically 1–2 pounds per week (6–8 pounds per month), though results depend on factors like adherence, activity level, and metabolism.

During the first 12 weeks, most patients start at a low dose that gradually increases as the body adjusts. It is normal not to see weight loss immediately since many patients spend the first few weeks allowing their body to adapt to the medication. During this period, you may notice a reduced appetite, smaller portions, and better control over cravings. Some mild side effects such as nausea or bloating can occur but usually improve with time. Beyond the first 12 weeks, EllieMD provides a check-in and reassessment every 3 months to evaluate your progress and determine if any adjustments are needed. The goal of treatment is not to continually increase the dose but to find your personal “sweet spot,” the dose where you feel your best and achieve steady, sustainable results. Each reassessment helps the provider fine-tune your next 3-month protocol to keep your plan safe, effective, and personalized. Individual results will vary as no two patients are the same. Some may notice changes sooner than others depending on metabolism, lifestyle, and medical history. What is most important is staying consistent and following the protocol assigned by the provider since steady adherence leads to the best long-term outcomes..

GLP-1 + B12 is a medication used to help with weight management and blood sugar control. It belongs to a class of drugs called GLP-1 receptor agonists, which mimic a natural hormone that helps regulate appetite and insulin levels. GLP-1 + B12 is FDA-approved for managing type 2 diabetes and, at higher doses, for chronic weight management in adults with obesity or overweight individuals with weight-related health conditions. It works by reducing hunger, slowing digestion, and improving blood sugar control.

People with Type 2 Diabetes: GLP-1 + B12 has been shown to improve glycemic control by enhancing insulin secretion and lowering blood sugar levels, making it a valuable adjunct in diabetes management. Individuals Seeking Weight Management: At the appropriate dose, GLP-1 + B12 can help reduce appetite and promote gradual, sustained weight loss, which can be beneficial for those struggling with obesity or weight-related health issues. Those with Metabolic Concerns: By improving blood sugar regulation and potentially favorably influencing cholesterol and blood pressure, GLP-1 + B12 may assist individuals dealing with metabolic syndrome or other related conditions. Patients with Cardiovascular Risk Factors: Improved metabolic health and weight loss can contribute to reducing risk factors associated with cardiovascular diseases, benefiting those at risk. Individuals Focused on Preventative Health: For those aiming to maintain long-term metabolic and cardiovascular health, GLP-1 + B12 can be part of a broader strategy to proactively manage and reduce age-related health risks.

To qualify, patients must be at least 18 years old, reside in or be physically present in an eligible state, and meet clinical requirements for treatment. EllieMD prescribes these medications for adults with a BMI of 25 or higher. Patients transferring from another weight-loss prescription program, even from a different telehealth platform or physician, may qualify with a BMI of 22 or higher. Per FDA guidance, GLP-1-based medications are generally approved for adults with a BMI over 30, or over 27 with a qualifying health condition such as type 2 diabetes, high blood pressure, or high cholesterol. Patients who are pregnant, nursing, or have certain conditions (such as pancreatitis, gallbladder disease, or thyroid cancer) may not be eligible. The provider will determine eligibility during your consultation.

Common side effects may include mild nausea, vomiting, diarrhea, or constipation, which typically improve as your body adjusts to the medication. These effects are generally temporary and can often be managed with hydration, smaller meals, and consistency. In rare cases, more serious reactions such as pancreatitis or kidney problems can occur. If you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, or anything that feels unusual, contact your primary care physician first, as they have your full medical history and can provide appropriate guidance. After doing so, update the Telehealth prescribing provider so that everyone involved in your care is informed. If you ever experience a severe or urgent medical emergency, such as difficulty breathing or intense pain, go to the nearest emergency room or call 911. While these reactions are uncommon, it’s always best to prioritize your safety and ensure all providers are kept in the loop.

Please note: only the lab order sheet is provided; lab fees are paid directly by the patient. Patients should always consult their primary care physician before starting any new treatment. This product is prescribed by a licensed healthcare provider based on individual needs. These statements and the product have not been evaluated or approved by the Food and Drug Administration (FDA). Compounded medications are not FDA-approved, and their safety and efficacy have not been independently verified by the FDA. The combined use of GLP-1 or GIP in compounded formulations has not been reviewed by the FDA for safety or effectiveness. This information is for educational purposes only and should not be considered medical advice.

Tesamorelin is a synthetic GHRH (growth hormone–releasing hormone) analog peptide that tells your pituitary gland to release more of your body’s own growth hormone, which then raises IGF-1 and can drive changes in body composition and metabolism. It is used for visceral fat reduction, metabolic support, and lean-mass preservation.  

Clinics and peptide researchers are actively using BPC-157 and TB-500 for injury recovery, connective tissue repair, joint and tendon support, improved mobility, and regenerative wellness. These recovery peptides are popular in sports performance and longevity medicine.